Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHARLES A SZABO

Allopathic & Osteopathic Physicians Psychiatry & Neurology Clinical Neurophysiology

NPI
1548277866
CMS profile
160309
Location
SAN ANTONIO, TX

General Payments · PY2018–2024

$22,834.43

  • Reported across 116 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$541.01

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $541.01 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Neurelis, Inc. $140.25 4
UCB, Inc. $130.82 5
Marinus Pharmaceuticals, Inc. $124.99 1
JAZZ PHARMACEUTICALS INC. $98.05 2
SK Life Science, Inc. $24.18 1
Otter Pharmaceuticals, LLC $22.72 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $8,164.03 34
PY2019 $7,254.50 30
PY2020 $3,072.96 5
PY2021 $436.25 12
PY2022 $610.66 11
PY2023 $2,755.02 10
PY2024 $541.01 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
JAZZ PHARMACEUTICALS INC. $67.84 02/28/2024 Food and Beverage Undisputed 01/23/2026 1150220224 CMS
JAZZ PHARMACEUTICALS INC. $30.21 05/06/2024 Food and Beverage Undisputed 01/23/2026 1150220226 CMS
Marinus Pharmaceuticals, Inc. $124.99 03/07/2024 Food and Beverage Undisputed 01/23/2026 1141324494 CMS
Neurelis, Inc. $32.44 02/05/2024 Food and Beverage Undisputed 01/23/2026 1145656487 CMS
Neurelis, Inc. $42.93 02/10/2024 Food and Beverage Undisputed 01/23/2026 1145656489 CMS
Neurelis, Inc. $32.44 10/23/2024 Food and Beverage Undisputed 01/23/2026 1145656493 CMS
Neurelis, Inc. $32.44 11/06/2024 Food and Beverage Undisputed 01/23/2026 1145656497 CMS
Otter Pharmaceuticals, LLC $22.72 08/29/2024 Food and Beverage Undisputed 01/23/2026 1148638176 CMS
SK Life Science, Inc. $24.18 02/06/2024 Food and Beverage Undisputed 01/23/2026 1154131181 CMS
UCB, Inc. $22.16 04/16/2024 Food and Beverage Undisputed 01/23/2026 1143245900 CMS
UCB, Inc. $16.11 05/01/2024 Food and Beverage Undisputed 01/23/2026 1143245904 CMS
UCB, Inc. $21.94 07/16/2024 Food and Beverage Undisputed 01/23/2026 1143245909 CMS
UCB, Inc. $49.42 08/05/2024 Food and Beverage Undisputed 01/23/2026 1143245913 CMS
UCB, Inc. $21.19 10/31/2024 Food and Beverage Undisputed 01/23/2026 1143245918 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.